S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
5 Semiconductor Giants: Navigating the Recent Pullback
3 Key Stocks Helping to Drive the EV Race
Breakout Alert: Coinbase's Consolidation Is About To End
Closing prices for crude oil, gold and other commodities
You Can Follow BlackRock’s Market View for Your Money
JPMorgan Chase Falls 5% as Consumer Cracking Begins to Show
JPMorgan Chase, Advanced Micro Devices fall; Progressive, State Street rise, 4/12/2024
NASDAQ:GLPG

Galapagos (GLPG) Stock Price, News & Analysis

$30.25
-0.60 (-1.94%)
(As of 04/12/2024 ET)
Today's Range
$30.24
$30.78
50-Day Range
$30.25
$39.71
52-Week Range
$30.24
$45.21
Volume
201,332 shs
Average Volume
117,521 shs
Market Capitalization
$1.99 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$34.50

Galapagos MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
14.0% Upside
$34.50 Price Target
Short Interest
Bearish
2.18% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.66mentions of Galapagos in the last 14 days
Based on 6 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.20) to $0.06 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.77 out of 5 stars

Medical Sector

870th out of 923 stocks

Pharmaceutical Preparations Industry

408th out of 432 stocks

GLPG stock logo

About Galapagos Stock (NASDAQ:GLPG)

Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of?various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and uveitis. The company's pipeline products also comprise GLPG3667 that has completed Phase 1b trial; and GLPG5101 and GLPG5201, CD19 CAR-T product candidate manufactures at point-of-care, that is in Phase I/II in relapsed/refractory non-Hodgkin lymphoma and chronic lymphocytic leukemia. The company has collaboration agreements with Gilead Sciences, Inc.; AbbVie S.à r.l.; and Novartis Pharma AG. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.

GLPG Stock Price History

GLPG Stock News Headlines

Galapagos (NASDAQ:GLPG) Sets New 12-Month Low at $31.22
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Bitcoin Rockets To Record High But Buy THIS Instead
Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…
Galapagos Enters Oversold Territory (GLPG)
GLPG Oct 2024 45.000 put
GLPG Apr 2024 42.500 put
Galapagos assumed with an Equal Weight at Morgan Stanley
GLPG Mar 2024 32.500 put
Galapagos price target lowered by EUR 4 at Barclays
Galapagos (GLPG) Gets a Hold from RBC Capital
GLPG Mar 2024 37.500 put
Galapagos FY 2023 Earnings Preview
GLPG Mar 2024 40.000 call
See More Headlines
Receive GLPG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Galapagos and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
4/12/2024
Next Earnings (Estimated)
5/02/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GLPG
Employees
1,123
Year Founded
1999

Price Target and Rating

Average Stock Price Target
$34.50
High Stock Price Target
$38.00
Low Stock Price Target
$31.00
Potential Upside/Downside
+14.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$229.12 million
Pretax Margin
2.35%

Debt

Sales & Book Value

Annual Sales
$259.40 million
Cash Flow
$0.63 per share
Book Value
$45.92 per share

Miscellaneous

Free Float
63,979,000
Market Cap
$1.99 billion
Optionable
Optionable
Beta
0.24

Social Links

The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Key Executives

  • Dr. Paulus A. Stoffels M.D. (Age 62)
    Ph.D., CEO, Chairman, Interim Head of R&D
    Comp: $974.86k
  • Mr. Thad Huston (Age 54)
    CFO & COO
  • Ms. Sofie Van Gijsel
    Head of Investor Relations
  • Ms. Valeria Cnossen
    General Counsel
  • Marieke Vermeersch
    Head of Corporate Communication
  • Ms. Annelies Missotten
    Chief Human Resources Officer
  • Ms. Ellen Van Der Aar
    Head of Development
  • Mr. Philippe Alen M.B.A.
    Ph.D., Pharm.D., Senior VP & Head of Business Development
  • Mr. Dirk De Naeyer
    Head of Development Operations
  • Ms. Alice Dietrich
    Head of Medical Affairs

GLPG Stock Analysis - Frequently Asked Questions

Should I buy or sell Galapagos stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Galapagos in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GLPG shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GLPG, but not buy additional shares or sell existing shares.
View GLPG analyst ratings
or view top-rated stocks.

What is Galapagos' stock price target for 2024?

5 brokerages have issued twelve-month price objectives for Galapagos' shares. Their GLPG share price targets range from $31.00 to $38.00. On average, they expect the company's stock price to reach $34.50 in the next twelve months. This suggests a possible upside of 14.0% from the stock's current price.
View analysts price targets for GLPG
or view top-rated stocks among Wall Street analysts.

How have GLPG shares performed in 2024?

Galapagos' stock was trading at $40.65 at the start of the year. Since then, GLPG stock has decreased by 25.6% and is now trading at $30.25.
View the best growth stocks for 2024 here
.

When is Galapagos' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 2nd 2024.
View our GLPG earnings forecast
.

What ETFs hold Galapagos' stock?

ETFs with the largest weight of Galapagos (NASDAQ:GLPG) stock in their portfolio include ALPS Medical Breakthroughs ETF (SBIO).ERShares NextGen Entrepreneurs ETF (ERSX).

What is Onno van de Stolpe's approval rating as Galapagos' CEO?

6 employees have rated Galapagos Chief Executive Officer Onno van de Stolpe on Glassdoor.com. Onno van de Stolpe has an approval rating of 100% among the company's employees. This puts Onno van de Stolpe in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Galapagos own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Galapagos investors own include Gilead Sciences (GILD), Celyad Oncology (CYAD), Intercept Pharmaceuticals (ICPT), NVIDIA (NVDA), argenx (ARGX), AbbVie (ABBV), Biogen (BIIB), Pharming Group (PHGUF), Trade Desk (TTD) and Collegium Pharmaceutical (COLL).

When did Galapagos IPO?

Galapagos (GLPG) raised $161 million in an initial public offering on Thursday, May 14th 2015. The company issued 3,800,000 shares at $42.43 per share. Morgan Stanley, Credit Suisse and Cowen and Company acted as the underwriters for the IPO and Nomura and Bryan, Garnier were co-managers.

Who are Galapagos' major shareholders?

Galapagos' stock is owned by a variety of institutional and retail investors. Top institutional investors include GAMMA Investing LLC (0.00%).

How do I buy shares of Galapagos?

Shares of GLPG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GLPG) was last updated on 4/13/2024 by MarketBeat.com Staff

From Our Partners